229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.23%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
10.31%
Positive gross profit growth while VUZI is negative. John Neff would see a clear operational edge over the competitor.
221.21%
EBIT growth above 1.5x VUZI's 11.13%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
221.21%
Operating income growth above 1.5x VUZI's 10.47%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
121.46%
Net income growth above 1.5x VUZI's 11.25%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
121.57%
EPS growth above 1.5x VUZI's 9.09%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
119.61%
Diluted EPS growth above 1.5x VUZI's 9.09%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.30%
Share count expansion well above VUZI's 0.33%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
9.59%
Diluted share count expanding well above VUZI's 0.33%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-33.33%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-33.16%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
48.51%
Positive 10Y revenue/share CAGR while VUZI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-25.32%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-47.06%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
58.56%
5Y OCF/share CAGR 1.25-1.5x VUZI's 51.30%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
-72.32%
Negative 3Y OCF/share CAGR while VUZI stands at 12.89%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
-72.42%
Negative 5Y net income/share CAGR while VUZI is 14.04%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-76.25%
Negative 3Y CAGR while VUZI is 36.24%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
-48.41%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-53.87%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while VUZI stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Negative near-term dividend growth while VUZI invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-12.85%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-7.55%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-2.53%
Negative asset growth while VUZI invests at 3.19%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.36%
1.25-1.5x VUZI's 2.76%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
-15.96%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-9.65%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.
